Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas A Levine

Showing results (1-10 of 256) with videos related to

Pageof 26
Sort By:
Gynecologic Oncology|July 21, 2018
The limits of aggressive surgical cytoreductionDouglas A Levine
Molecular Cancer Therapeutics|April 4, 2014
New insights into PARP inhibitors' effect on cell cycle and homology-directed DNA damage repairPetar Jelinic, Douglas A Levine
Gynecologic Oncology|February 13, 2013
Gynecologic cancer genomics in the modern eraDouglas A Levine, Elizabeth M Swisher
Gynecologic Oncology|July 1, 2008
Exosomal microRNAs step into the biomarker arenaKarin K Shih, Douglas A Levine
BMC Medical Genomics|June 11, 2016
Study design and data analysis considerations for the discovery of prognostic molecular biomarkers: a case study of progression free survival in advanced serous ovarian cancerLi-Xuan Qin, Douglas A Levine
Oncology (Williston Park, N.Y.)|July 31, 2003
Prophylactic surgery in hereditary breast/ovarian cancer syndromeDouglas A Levine, Mary L Gemignani
Gynecologic Oncology|July 24, 2008
44th Annual Meeting of the American Society of Clinical OncologyRobert L Coleman, Douglas A Levine
Cancer Journal (Sudbury, Mass.)|June 22, 2002
Update in the management of endometrial cancerDouglas A Levine, William J Hoskins
Gynecologic Oncology|August 3, 2011
The evolving pathogenesis model of high-grade pelvic serous carcinomaJoyce N Barlin, Douglas A Levine
Nature|April 24, 2020
A catalogue of cancer-driving mutations in healthy tissueVictoria L Bae-Jump, Douglas A Levine
Pageof 26

Showing results (1-10 of 256) with videos related to

Sort By:
Pageof 26
Gynecologic Oncology|July 21, 2018
The limits of aggressive surgical cytoreductionDouglas A Levine
Molecular Cancer Therapeutics|April 4, 2014
New insights into PARP inhibitors' effect on cell cycle and homology-directed DNA damage repairPetar Jelinic, Douglas A Levine
Gynecologic Oncology|February 13, 2013
Gynecologic cancer genomics in the modern eraDouglas A Levine, Elizabeth M Swisher
Gynecologic Oncology|July 1, 2008
Exosomal microRNAs step into the biomarker arenaKarin K Shih, Douglas A Levine
BMC Medical Genomics|June 11, 2016
Study design and data analysis considerations for the discovery of prognostic molecular biomarkers: a case study of progression free survival in advanced serous ovarian cancerLi-Xuan Qin, Douglas A Levine
Oncology (Williston Park, N.Y.)|July 31, 2003
Prophylactic surgery in hereditary breast/ovarian cancer syndromeDouglas A Levine, Mary L Gemignani
Gynecologic Oncology|July 24, 2008
44th Annual Meeting of the American Society of Clinical OncologyRobert L Coleman, Douglas A Levine
Cancer Journal (Sudbury, Mass.)|June 22, 2002
Update in the management of endometrial cancerDouglas A Levine, William J Hoskins
Gynecologic Oncology|August 3, 2011
The evolving pathogenesis model of high-grade pelvic serous carcinomaJoyce N Barlin, Douglas A Levine
Nature|April 24, 2020
A catalogue of cancer-driving mutations in healthy tissueVictoria L Bae-Jump, Douglas A Levine
Pageof 26